The data of Jiménez research work [13] appeared to not fit with those of Honikl and coworkers [35], who reported how in 60 glioblastoma patients, the increase of aromatase is concomitant with a longer survival even though the intratumoral estradiol concentrations are not documented. The gene discussed is CYP19A1; the disease is glioblastoma.